Skip to main content
Clinical Trials/NCT01810991
NCT01810991CompletedNot Applicable

Investigation of Hyperhidrosis Treatment Using the Nd: YAG 1440nm Wavelength Laser

Cynosure, Inc.1 site in 1 country19 target enrollmentStarted: June 1, 2012Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
19
Locations
1
Primary Endpoint
Percentage of Photographs Identified Accurately

Study Overview

Brief Summary

The purpose of this study is to evaluate the safety and efficacy of the Nd:YAG 1440 nm wavelength laser for the treatment of primary hyperhidrosis of the axilla.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to 85 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •A healthy non-smoking male or female between 18-56 years of age
  • •Understand/accept obligation not to receive any other procedures in anatomical areas exhibiting axillary hyperhidrosis through 3 months prior to treatment
  • •Understand and accept the obligation and is logistically able to present for all scheduled follow-up visits
  • •Clinically diagnosed for primary hyperhidrosis of the axilla.
  • •A self assessed Hyperhidrosis Disease Severity Scale (HDSS) score of three (3) or four (4)

Exclusion Criteria

  • •Clinical diagnosis of secondary hyperhidrosis
  • •Uncontrolled systemic disease
  • •Concurrent use of any hyperhidrosis treatments other than over the counter antiperspirants or deodorants
  • •Receipt of Botox or Dysport within the past six months
  • •Patients who refuse to stop using over the counter antiperspirants 24 hours prior to the day of surgery and each of the follow-up visits at 3 months and 6 months that Minors starch iodine tests may be performed.
  • •Patients using or having used within 7 days of baseline visit: cholinomimetic agents, anticholinergic agents, prescription antiperspirants, any herbal medicine treatments or any other treatments for hyperhidrosis except over the counter antiperspirant or planning to use such agents during the course of the study.
  • •Any previous liposuction/liposculpture or any type of surgery for hyperhidrosis; OR any other types of treatments for hyperhidrosis in the area to be treated in the past 6 months or planning to have any treatments for hyperhidrosis or surgery within the treatment area during the course of the study.
  • •Allergies to medication or local anesthesia required for the procedure
  • •A history of thrombophlebitis
  • •A history of acute infections
  • •A history of heart failure
  • •Received or is anticipated to receive antiplatelets, anticoagulants, thrombolytics, vitamin E or anti inflammatories within 2 weeks pre treatment
  • •An intolerance to anesthesia
  • •Any medical condition, that, in the investigator's opinion would interfere with the patient's participation in the study
  • •Taking medications that are photosensitive
  • •A history of keloid formation
  • •Is pregnant or has been pregnant in the last 3 months, currently breast feeding or planning a pregnancy during the course of the study
  • •Study subjects that can not maintain their pre-study exercise and diet routine over the course of the study

Arms & Interventions

Nd:YAG Laser

Experimental

Nd:YAG 1440nm Laser

Intervention: Nd:YAG Laser (Device)

Outcomes

Primary Outcomes

Percentage of Photographs Identified Accurately

Time Frame: 6 Month Follow Up

3 trained blinded evaluators were asked to pick the post treatment photo from pre and post treatment photograph sets.

Percentage of Photographs Identified Accurately

Time Frame: 3 Month Follow Up

3 trained blinded evaluators were asked to pick the post treatment photo from pre and post treatment photograph sets.

Secondary Outcomes

  • Number of Participants With Changed and Unchanged Glands on Biopsy Sampling(up to 3 months post last treatment)

Investigators

Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials